165 related articles for article (PubMed ID: 34224145)
1. Increased cutaneous squamous cell carcinoma risk with hydrochlorothiazide use: is there a safe alternative?
Hollestein LM; Arnspang Pedersen S
Br J Dermatol; 2021 Aug; 185(2):244-245. PubMed ID: 34224145
[No Abstract] [Full Text] [Related]
2. In Brief: Hydrochlorothiazide and skin cancer.
Med Lett Drugs Ther; 2020 Nov; 62(1611):177. PubMed ID: 33429413
[No Abstract] [Full Text] [Related]
3. [Hydrochlorothiazide use and risk of skin cancers: A systematic review].
Becquart O; Guillot B; Bourrain JL; Duflos C; Du-Thanh A
Rev Med Interne; 2019 Sep; 40(9):617-622. PubMed ID: 31101331
[TBL] [Abstract][Full Text] [Related]
4. Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control study.
Adalsteinsson JA; Muzumdar S; Waldman R; Hu C; Wu R; Ratner D; Ungar J; Silverberg JI; Olafsdottir GH; Kristjansson AK; Tryggvadottir L; Jonasson JG
J Am Acad Dermatol; 2021 Mar; 84(3):669-675. PubMed ID: 32791082
[TBL] [Abstract][Full Text] [Related]
5. Hydrochlorothiazide Use and Increased Squamous Cell Carcinoma Burden in a High-Risk Mohs Population: A Cross-Sectional Study.
Han S; Wolfe CM; Angnardo L; Pedersen SA; Gaist D; Pottegård A; Cognetta AB
Dermatol Surg; 2020 May; 46(5):704-708. PubMed ID: 30865018
[No Abstract] [Full Text] [Related]
6. Hydrochlorothiazide use is associated with the risk of cutaneous and lip squamous cell carcinoma: A systematic review and meta-analysis.
de Macedo Andrade AC; Felix FA; França GM; Ribeiro ILA; Barboza CAG; de Castro RD; de Lisboa Lopes Costa A
Eur J Clin Pharmacol; 2022 Jun; 78(6):919-930. PubMed ID: 35258665
[TBL] [Abstract][Full Text] [Related]
7. Severe widespread actinic damage and squamous cell carcinoma: could hydrochlorothiazide be implicated? A report of two cases.
Randhawa A; Wylie G
Br J Hosp Med (Lond); 2020 Mar; 81(3):1-3. PubMed ID: 32240009
[No Abstract] [Full Text] [Related]
8. [Hydrochlorothiazide and skin cancer].
Olde Engberink RHG; van der Hoeven NV; Zwinderman AH; van den Born BH
Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120217
[TBL] [Abstract][Full Text] [Related]
9. Hydrochlorothiazide use and risk of non-melanoma skin cancer in Spain: A case/non-case study.
Lecaros-Astorga DA; Molina-Guarneros JA; Rodríguez-Jiménez P; Martin-Arias LH; Sainz-Gil M
Int J Clin Pharmacol Ther; 2021 Apr; 59(4):280-288. PubMed ID: 33355085
[TBL] [Abstract][Full Text] [Related]
10. Use of hydrochlorothiazide and risk of nonmelanoma skin cancer: a pilot study in the Brazilian population.
Tiba APL; Cury-Martins J; Miyashiro DR; Sanches JA
Int J Dermatol; 2022 Jun; 61(6):e213-e214. PubMed ID: 34480765
[No Abstract] [Full Text] [Related]
11. Squamous-cell carcinoma arising in a basal-cell epithelioma treated with 5-fluorouracil.
Kurtis B; Rosen T
J Dermatol Surg Oncol; 1979 May; 5(5):394-6. PubMed ID: 458006
[TBL] [Abstract][Full Text] [Related]
12. Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: A series of population-based nested case-control studies.
Morales DR; Pacurariu A; Slattery J; Kurz X
Br J Clin Pharmacol; 2020 Jul; 86(7):1336-1345. PubMed ID: 32068906
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous malignancy related to cyclosporin A therapy.
Green C; Hawk JL
Clin Exp Dermatol; 1993 Jan; 18(1):30-1. PubMed ID: 8440049
[No Abstract] [Full Text] [Related]
14. Hydrochlorothiazide use and risk for Merkel cell carcinoma and malignant adnexal skin tumors: A nationwide case-control study.
Pedersen SA; Johannesdottir Schmidt SA; Hölmich LR; Friis S; Pottegård A; Gaist D
J Am Acad Dermatol; 2019 Feb; 80(2):460-465.e9. PubMed ID: 29913261
[TBL] [Abstract][Full Text] [Related]
15. Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: A population-based case-control study.
Daniels B; Pearson SA; Vajdic CM; Pottegård A; Buckley NA; Zoega H
Basic Clin Pharmacol Toxicol; 2020 Oct; 127(4):320-328. PubMed ID: 32608576
[TBL] [Abstract][Full Text] [Related]
16. Hydrochlorothiazide treatment and risk of non-melanoma skin cancer: Review of the literature.
Garrido PM; Borges-Costa J
Rev Port Cardiol (Engl Ed); 2020 Mar; 39(3):163-170. PubMed ID: 32354458
[TBL] [Abstract][Full Text] [Related]
17. Hydrochlorothiazide and squamous cell carcinoma.
O'Neill B; Moe S; Korownyk C
Can Fam Physician; 2020 Feb; 66(2):116. PubMed ID: 32060193
[No Abstract] [Full Text] [Related]
18. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
[TBL] [Abstract][Full Text] [Related]
19. Skin cancer and immunosuppression.
Walder BK; Robertson MR; Jeremy D
Lancet; 1971 Dec; 2(7737):1282-3. PubMed ID: 4143536
[TBL] [Abstract][Full Text] [Related]
20. Iatrogenic immunosuppression and cutaneous malignancy.
DePry JL; Reed KB; Cook-Norris RH; Brewer JD
Clin Dermatol; 2011; 29(6):602-13. PubMed ID: 22014982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
